Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 345.04 Million CNY | 34.56% |
| 2022 | 256.42 Million CNY | 26.22% |
| 2021 | 203.15 Million CNY | 29.78% |
| 2020 | 156.53 Million CNY | 38.37% |
| 2019 | 113.12 Million CNY | 26.19% |
| 2018 | 89.64 Million CNY | 64.78% |
| 2017 | 54.4 Million CNY | 585.69% |
| 2016 | -11.2 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 48.66 Million CNY | -58.11% |
| 2024 Q3 | 76.03 Million CNY | 56.23% |
| 2024 Q1 | 116.18 Million CNY | -6.96% |
| 2023 Q3 | 67.22 Million CNY | 31.05% |
| 2023 Q1 | 101.63 Million CNY | 7.63% |
| 2023 FY | 345.04 Million CNY | 34.56% |
| 2023 Q4 | 124.87 Million CNY | 85.76% |
| 2023 Q2 | 51.29 Million CNY | -49.53% |
| 2022 Q3 | -13.37 Million CNY | -140.89% |
| 2022 Q2 | 32.71 Million CNY | -57.26% |
| 2022 Q1 | 76.54 Million CNY | 3.78% |
| 2022 FY | 256.42 Million CNY | 26.22% |
| 2022 Q4 | 94.43 Million CNY | 805.91% |
| 2021 Q3 | 41.01 Million CNY | 44.25% |
| 2021 FY | 203.15 Million CNY | 29.78% |
| 2021 Q4 | 73.75 Million CNY | 79.84% |
| 2021 Q2 | 28.43 Million CNY | -52.58% |
| 2021 Q1 | 59.95 Million CNY | 19.74% |
| 2020 Q4 | 50.07 Million CNY | 69.72% |
| 2020 Q3 | 29.5 Million CNY | -18.12% |
| 2020 Q1 | 40.92 Million CNY | 13.05% |
| 2020 FY | 156.53 Million CNY | 38.37% |
| 2020 Q2 | 36.03 Million CNY | -11.97% |
| 2019 Q2 | 26.47 Million CNY | -18.57% |
| 2019 FY | 113.12 Million CNY | 26.19% |
| 2019 Q4 | 36.2 Million CNY | 101.91% |
| 2019 Q3 | 17.93 Million CNY | -32.27% |
| 2019 Q1 | 32.51 Million CNY | -11.13% |
| 2018 Q4 | 36.58 Million CNY | 0.0% |
| 2018 FY | 89.64 Million CNY | 64.78% |
| 2017 FY | 54.4 Million CNY | 585.69% |
| 2016 FY | -11.2 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 162.22 Million CNY | -112.696% |